COVID-19 Is a Stress Test Exposing Structural Hurdles in Both Our Financial System and Society
We are in strange and scary times. We are at war with a virus which is all the more deadly in that it cannot be easily discerned but it is metastasizing geometrically. Moreover, COVID-19 and the measures required to contain…
The Sweet Spot in the US Equity Markets – Part 3
In the last post in this series, we update and expand on our analysis to explore the impact of rising and falling interest rates on the performance of various capitalization tranches. Finally, we now look at the performance of the “Sweet Spot” in different interest rate regimes.
Will U.S. Equities Continue to Trounce Non-U.S. Equities?
For global equity investors, the decade ending on December 31, 2019 was undoubtedly the American decade. The performance of U.S. equities more than doubled and in many cases tripled other countries and regions such as emerging markets…
2020 Outlook for Emerging and Frontier Markets
While the U.S. continued its decade-long run, surging ahead another +31% in 2019 to lead all major developed markets (except Switzerland, +32.5%), three emerging markets did even better last year. Taiwan gained +36% as investors reevaluated the “moat” of its market champion, …
Microbes, Markets, and the Dragon
The coronavirus outbreak in China, named COVID-19 by WHO, is understandably dominating news coverage and depressing Chinese risk plays. Since 12/9/2019 when the first coronavirus case was announced from the City of Wuhan, confirmed cases have risen rapidly to over 40,000 as of this report.